LifeVantage Co. (NASDAQ:LFVN – Get Free Report) announced a quarterly dividend on Wednesday, February 5th,RTT News reports. Investors of record on Monday, March 3rd will be given a dividend of 0.04 per share on Monday, March 17th. This represents a $0.16 dividend on an annualized basis and a yield of 0.84%. The ex-dividend date is Monday, March 3rd.
LifeVantage has a dividend payout ratio of 15.4% meaning its dividend is sufficiently covered by earnings.
LifeVantage Stock Down 16.5 %
NASDAQ:LFVN opened at $18.99 on Friday. The firm has a market cap of $237.75 million, a PE ratio of 59.35 and a beta of 0.84. LifeVantage has a 12 month low of $5.22 and a 12 month high of $27.38. The company’s 50-day moving average price is $19.14 and its two-hundred day moving average price is $13.66.
Analyst Upgrades and Downgrades
Several equities research analysts have commented on the stock. Lake Street Capital began coverage on shares of LifeVantage in a research note on Thursday, December 19th. They issued a “buy” rating and a $26.00 target price for the company. Craig Hallum began coverage on shares of LifeVantage in a research report on Tuesday, January 14th. They set a “buy” rating and a $35.00 price objective for the company.
Get Our Latest Stock Analysis on LifeVantage
LifeVantage Company Profile
LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.
Further Reading
- Five stocks we like better than LifeVantage
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- These are the 3 Stocks Most Likely to Split in 2025
- Best Stocks Under $10.00
- Price Plunge in Roblox Presents Opportunity for Robust Gains
- What Investors Need to Know About Upcoming IPOs
- Billions in Buybacks: 4 Stocks Rewarding Shareholders Now
Receive News & Ratings for LifeVantage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeVantage and related companies with MarketBeat.com's FREE daily email newsletter.